NEW YORK (GenomeWeb News) – Illumina reported after the close of the market on Tuesday that revenues in its fourth quarter increased 25 percent year over year, including a 21 percent bump in product revenues.

The San Diego-based company said that for the last three months of 2013, it took in $387.3 million in total revenues, up from $309.3 million in the year-ago period and besting the average analyst estimate of $382.1 million.

The results were in line with what Illumina had pre-announced earlier this month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.